53 related articles for article (PubMed ID: 34507900)
41. Fatty Pancreas-Centered Metabolic Basis of Pancreatic Adenocarcinoma: From Obesity, Diabetes and Pancreatitis to Oncogenesis.
Chang ML
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327494
[TBL] [Abstract][Full Text] [Related]
42. CT-Derived Body Composition Assessment as a Prognostic Tool in Oncologic Patients: From Opportunistic Research to Artificial Intelligence-Based Clinical Implementation.
Bates DDB; Pickhardt PJ
AJR Am J Roentgenol; 2022 Oct; 219(4):671-680. PubMed ID: 35642760
[TBL] [Abstract][Full Text] [Related]
43. Pancreatic Cancer Imaging: A New Look at an Old Problem.
Chu LC; Park S; Kawamoto S; Yuille AL; Hruban RH; Fishman EK
Curr Probl Diagn Radiol; 2021; 50(4):540-550. PubMed ID: 32988674
[TBL] [Abstract][Full Text] [Related]
44. Determining age and sex-specific distribution of pancreatic whole-gland CT attenuation using artificial intelligence aided image segmentation: Associations with body composition and pancreatic cancer risk.
Janssens LP; Weston AD; Singh D; Spears G; Harmsen WS; Takahashi N; Philbrick KA; Erickson BJ; Abu Dayyeh BK; Chari ST; Chandrasekhara V; Gleeson FC; Levy MJ; Pearson RK; Petersen BT; Vege SS; Majumder S
Pancreatology; 2021 Dec; 21(8):1524-1530. PubMed ID: 34507900
[TBL] [Abstract][Full Text] [Related]
45. CT and MRI of pancreatic tumors: an update in the era of radiomics.
Bartoli M; Barat M; Dohan A; Gaujoux S; Coriat R; Hoeffel C; Cassinotto C; Chassagnon G; Soyer P
Jpn J Radiol; 2020 Dec; 38(12):1111-1124. PubMed ID: 33085029
[TBL] [Abstract][Full Text] [Related]
46. Artificial intelligence for the detection of pancreatic lesions.
Anta JA; Martínez-Ballestero I; Eiroa D; García J; Rodríguez-Comas J
Int J Comput Assist Radiol Surg; 2022 Oct; 17(10):1855-1865. PubMed ID: 35951286
[TBL] [Abstract][Full Text] [Related]
47. Artificial intelligence and imaging for risk prediction of pancreatic cancer: a narrative review.
Qureshi TA; Javed S; Sarmadi T; Pandol SJ; Li D
Chin Clin Oncol; 2022 Feb; 11(1):1. PubMed ID: 35144387
[TBL] [Abstract][Full Text] [Related]
48. [Current CT developments in imaging of pancreatic diseases].
Wöltjen MM; Kröger JR
Radiologie (Heidelb); 2023 Dec; 63(12):878-885. PubMed ID: 37947865
[TBL] [Abstract][Full Text] [Related]
49. Pancreatic Adenocarcinoma: Imaging Modalities and the Role of Artificial Intelligence in Analyzing CT and MRI Images.
Anghel C; Grasu MC; Anghel DA; Rusu-Munteanu GI; Dumitru RL; Lupescu IG
Diagnostics (Basel); 2024 Feb; 14(4):. PubMed ID: 38396476
[TBL] [Abstract][Full Text] [Related]
50.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
